Paratek Pharmaceuticals Q1 2023 Earnings Preview
- Paratek Pharmaceuticals (NASDAQ:PRTK) is scheduled to announce Q1 earnings results on Tuesday, May 9th, after market close.
- The consensus EPS Estimate is -$0.35 and the consensus Revenue Estimate is $31.63M (+27.2% Y/Y).
- Over the last 3 months, EPS estimates have seen 0 upward revisions and 1 downward. Revenue estimates have seen 0 upward revisions and 2 downward.